TCL Archive Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma December 31, 2010
TCL Archive NCI Director Andrew von Eschenbach To Resign June 10, Remain As FDA Acting Commissioner. June 2, 2006
TCL Archive ASCO Backs Central IRB For Cancer Trials, Stiffens Conflict-of-Interest Policies May 2, 2003
TCL Archive Eppley Probe Could Lead to Tighter Reporting By NIH supported Investigators June 17, 1977
TCL Archive ODAC Nixes Sanofi’s VTE Drug in 14-1 Vote, Setting High Bar For Adjunctive Therapies June 22, 2012
